Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis

IMPORTANCE: Debate continues about the value of event adjudication in clinical trials and whether independent centralized assessments improve reliability and validity of study results in masked randomized trials compared with local, investigator-assessed end points. OBJECTIVE: To assess the results...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Netw Open
Main Authors: Farrant, Mary, Easton, J. Donald, Adelman, Eric E., Cucchiara, Brett L., Barsan, William G., Tillman, Holly J., Elm, Jordan J., Kim, Anthony S., Lindblad, Anne S., Palesch, Yuko Y., Zhao, Wenle, Pauls, Keith, Walsh, Kyle B., Martí-Fàbregas, Joan, Bernstein, Richard A., Johnston, S. Claiborne
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735409/
https://ncbi.nlm.nih.gov/pubmed/31490536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.10769
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados